October 25, 2021
Viviane J. Tschan receives EANM Marie-Curie Award
Viviane Tschan, PhD student in the Nuclide Chemistry group at the Center for Radiopharmaceutical Sciences (PSI), received this year’s Marie Curie Award for a new concept of radioligand therapy of prostate cancer.
August 10, 2021
5th call for proposals: 23 projects funded
PHRT published the approved projects for the 5th Call for iDoc, TPdF and Technology Translation projects
May 31, 2021
4th call for proposals: approved projects
Through “Pioneer Imaging Projects” (PIP), PHRT explores strategies, approaches, methods and options for a new Clinical Imaging Hub in the ETH Domain. During the second PHRT phase, these PIPs shall transform into a multi-centric Clinical Imaging Hub that will sustain after PHRT comes to its end in 2024. Click here to see the approved projects.
May 25, 2021
PHRT factsheet phase II
Click here to read our PHRT factsheet on the milestones of the first phase and the goals for phase II.
November 18, 2020
ETH Board approves second phase of PHRT for 2021-2024
The ETH Board has approved a second phase of Personalized Health and Related Technologies (PHRT), one of the ETH Domain’s four strategic focus areas. PHRT will launch its next call for proposals at the beginning of 2021.
November 14, 2019
3rd call for proposals: approved projects
With its 3rd call for proposals, PHRT invited clinical scientists, who have access to an extensive sample cohort, to create an inter-institutional, interdisciplinary consortium to formulate a well-defined clinical question to request funding to generate matched genomic, transcriptomic and proteomic data by the two PHRT platforms. Based on the suggestion of the Review Panel, the Executive Committee approved 3 of 8 projects, which will be supported with CHF 1,5 million.
June 24, 2019
New chairperson for the Executive Committee
Prof. Dr. Ruedi Aebersold resigned as the chairperson of the PHRT Executive Committee by May 22, 2019 and is succeeded by Prof. Dr. Bernd Wollscheid.